GMSCs delayed the onset of diabetes by downregulating IL-17 and IFN-γ levels in CD4+ and CD8+ T cells in spleens, pancreatic lymph nodes (pLN), and other lymph nodes via expressing CD39 and CD73 (43). The gene discussed is CD4; the disease is diabetes mellitus.